U.S. market Closed. Opens in 10 hours 12 minutes

HROWL | Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-05-31
Revenue130.19M88.59M72.48M48.87M51.16M41.37M26.77M19.94M9.72M1.66M10.00K100.00KN/AN/AN/AN/AN/AN/A
Cost of Revenue39.64M25.38M18.21M14.46M16.75M16.52M13.51M9.83M5.21M1.09MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit90.55M63.21M54.26M34.41M34.42M24.85M13.27M10.11M4.51M567.41K10.00K100.00KN/AN/AN/AN/AN/AN/A
Operating Expenses90.12M61.29M52.40M33.66M35.18M30.07M25.43M25.69M19.33M10.71M7.70M4.28M939.23K2.50M4.56M3.75M2.86M46.21K
Selling, General & Admin83.09M58.24M41.31M31.25M33.10M29.24M25.02M24.95M19.00M10.48M6.08M2.98M827.67K2.31M1.60M1.76M2.86M6.21K
Research & Development6.88M3.05M11.08M2.41M2.08M825.00K413.00K739.00K332.00K236.66K1.62M1.30M111.55K194.59K2.97M1.99M1.83M150.00K
Other Operating ExpensesN/A-15.93M-19.49M-3.80M630.00K103.00KN/A1.54M31.00KN/AN/AN/AN/AN/AN/AN/AN/A-110.00K
Operating Income431.00K-1.75M-284.00K-1.63M-503.00K-5.22M-12.16M-15.88M-14.82M-10.15M-7.69M-4.18M-939.23K-2.50M-4.56M-3.75M-2.86M-46.21K
Other Expenses / Income-24.37M-15.93M-19.49M-3.80M386.00K19.84M-757.00K-3.32M-1.08M28.65K43.76K-1.20M-14.71K-28.67K10.44K375.00K-1.43M-533.79K
Before Tax Income-23.94M-14.01M-17.87M-3.42M-125.00K14.62M-12.92M-19.20M-15.90M-10.12M-7.64M-5.38M-953.94K-2.53MN/A-3.37M-2.77M-580.00K
Income Tax Expenses470.00K75.00K133.00K4.00K2.47M-19.45M-935.00K-111.00K1.08M-28.65K-43.76K1.20M-60.29K-26.30K-10.44K-817.01K-228.27K10.00K
Net Income-24.41M-14.09M-18.01M-3.42M-2.59M14.62M-11.98M-19.09M-15.90M-10.12M-7.64M-5.38M-953.94K-2.53M-4.55M-3.30M-4.28M-46.21K
Interest Expenses21.32M7.24M5.44M2.24M2.50M2.73M3.03M6.00M1.12M3.80KN/A24.66K75.00K55.48KN/AN/A1.56M-10.00K
Basic Shares Outstanding32.62M27.46M26.76M25.90M25.32M23.81M19.98M12.74M9.58M9.13M8.66M4.49M397.80K394.63K390.32K370.55K221.17K185.01K
Diluted Shares Outstanding32.62M27.46M26.76M25.90M26.47M23.81M20.03M12.74M9.58M9.13M8.66M4.49M397.80K394.63K390.32K370.55K221.17K185.01K
EBITDA9.72M-3.20M-10.14M3.49M1.44M-2.73M-10.40M-14.06M-14.21M-10.06M-7.64M-5.36M-878.60K-2.47M-4.55M-4.12M-2.75M-46.21K
EBITDA Margin7.47%-3.62%-13.99%7.14%2.81%-6.61%-38.84%-70.49%-146.27%-606.05%-76,374.65%-5,355.93%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-2.62M-6.77M-12.44M-1.18M2.38M-2.10M-9.89M-13.20M-13.70M-10.14M-7.69M-4.16M-939.23K-2.50M-4.56M-4.12M-2.95M-46.21K
EBIT Margin-2.01%-7.64%-17.16%-2.41%4.64%-5.07%-36.95%-66.18%-141.01%-610.93%-76,868.79%-4,163.47%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-05-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙